Role of Smoking in the Evolution of Cardiovascular Magnetic Resonance and Laboratory Findings of Acute Myocarditis.

Acute myocarditis cardiac magnetic resonance cigarette smoking follow-up late gadolinium enhancement troponin I

Journal

Heart views : the official journal of the Gulf Heart Association
ISSN: 1995-705X
Titre abrégé: Heart Views
Pays: India
ID NLM: 101316474

Informations de publication

Date de publication:
Historique:
received: 22 07 2019
accepted: 15 09 2019
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: ppublish

Résumé

The purpose is to investigate cardiac magnetic resonance and laboratory findings in patients with clinically suspected acute myocarditis and re-assess the evolution of findings in relation to clinical parameters and smoking habits. We prospectively analyzed 68 consecutive patients (4 females, 64 males, median age 25 years) at baseline and 51 patients 12 months later with regard to age, symptoms, and signs, smoking history, cardiac troponin I, erythrocyte sedimentation rate, c-reactive protein blood levels, electrocardiography changes, and cardiac magnetic resonance findings. Statistical analysis included group comparisons and linear regression between clinical parameters and the obtained data. A statistically significant correlation was recorded between smoking and late gadolinium enhancement extent, both at baseline and follow-up study. Late gadolinium enhancement extent was positively associated with cardiac troponin I serum levels and c-reactive protein and negatively with left ventricular ejection fraction at baseline study. Myocardial segments 4 and 5 were most frequently involved. Late gadolinium enhancement persisted in 96% of patients with no significant extent change at 12-month follow-up, while improved. A strong correlation was recorded between smoking patients with acute myocarditis and extent both at baseline and follow-up cardiac magnetic resonance. Myocardial segments 4 and 5 involvement was most prevalent. Late gadolinium enhancement persisted at follow-up, its incidence was higher than that reported in other studies and did not have an impact on the patient's clinical status or cardiac function. However, longer-term follow-up is highly recommended in these patients.

Identifiants

pubmed: 32082496
doi: 10.4103/HEARTVIEWS.HEARTVIEWS_68_19
pii: HV-21-22
pmc: PMC7006323
doi:

Types de publication

Journal Article

Langues

eng

Pagination

22-30

Informations de copyright

Copyright: © 2020 Heart Views.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

J Am Heart Assoc. 2016 Jul 19;5(7):
pubmed: 27436306
JACC Cardiovasc Imaging. 2012 May;5(5):513-24
pubmed: 22595159
Mayo Clin Proc. 2009 Nov;84(11):1001-9
pubmed: 19880690
J Am Coll Cardiol. 1997 Nov 1;30(5):1354-9
pubmed: 9350939
Radiologia. 2013 Jul-Aug;55(4):294-304
pubmed: 23098997
Can J Physiol Pharmacol. 2010 May;88(5):568-75
pubmed: 20555426
Circulation. 2006 Oct 10;114(15):1581-90
pubmed: 17015795
Annu Rev Pathol. 2008;3:127-55
pubmed: 18039131
Int J Cardiovasc Imaging. 2012 Feb;28(2):327-35
pubmed: 21347598
Circulation. 2008 Aug 5;118(6):639-48
pubmed: 18645053
Am J Cardiovasc Pathol. 1987 Jan;1(1):3-14
pubmed: 3455232
Herz. 2000 May;25(3):279-85
pubmed: 10904853
J Am Coll Cardiol. 2017 Oct 17;70(16):1964-1976
pubmed: 29025553
Circ Cardiovasc Imaging. 2018 Jul;11(7):e007598
pubmed: 30012826
J Am Coll Cardiol. 2000 Jul;36(1):227-32
pubmed: 10898439
Circulation. 2006 Apr 11;113(14):1807-16
pubmed: 16567565
J Cardiovasc Magn Reson. 2015 Aug 29;17:78
pubmed: 26318624
Circ Cardiovasc Imaging. 2013 Sep;6(5):833-9
pubmed: 24046380
J Cardiovasc Med (Hagerstown). 2015 Oct;16(10):696-703
pubmed: 24933194
J Am Coll Cardiol. 2006 Apr 18;47(8):1649-54
pubmed: 16631005
J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87
pubmed: 19389557
J Am Coll Cardiol. 1992 Jul;20(1):85-9
pubmed: 1607543
Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1140-4
pubmed: 24925145
Neth Heart J. 2009 Dec;17(12):481-6
pubmed: 20087452
J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):1029-33
pubmed: 18163015
MAGMA. 2003 Feb;16(1):17-20
pubmed: 12695882
World J Cardiol. 2014 Jul 26;6(7):585-601
pubmed: 25068019
Curr Pharm Des. 2008;14(18):1771-7
pubmed: 18673180
Clin Res Cardiol. 2015 Feb;104(2):154-63
pubmed: 25315045
Heart Asia. 2016 Oct 26;8(2):54-55
pubmed: 27843498
Eur Heart J Cardiovasc Imaging. 2017 Jul 1;18(7):744-751
pubmed: 28329275
Jpn J Radiol. 2012 Dec;30(10):824-31
pubmed: 22956366
Eur J Heart Fail. 2011 Aug;13(8):830-7
pubmed: 21632580
Eur Heart J. 2007 Jun;28(11):1326-33
pubmed: 17493945
Cardiol Res. 2017 Aug;8(4):172-175
pubmed: 28868104
J Am Coll Cardiol. 2017 Oct 17;70(16):1977-1987
pubmed: 29025554
Med Microbiol Immunol. 2004 May;193(2-3):101-7
pubmed: 12920583
Circulation. 2007 Nov 6;116(19):2216-33
pubmed: 17959655
Heart. 2006 Mar;92(3):316-20
pubmed: 15923280

Auteurs

Efstathios Detorakis (E)

Department of Radiology, Magnetic Resonance Imaging Unit, Affidea Diagnostic Center, Greece.

Rowland Illing (R)

Prof. Rowland Illing, Interventional Oncology Service, University College Hospital, London, UK.

Ismini Lasithiotaki (I)

Department of Thoracic Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece.

Emmanouil Foukarakis (E)

Department of Cardiology, Venizeleio General Hospital, Heraklion, Crete, Greece.

Maria Raissaki (M)

Department of Radiology, University Hospital of Heraklion, Heraklion, Crete, Greece.

Classifications MeSH